Article info

Download PDFPDF

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma

Authors

  • Pouyan N. Changizzadeh Division of Hematology and OncologyRoger Williams Medical Center 02908 Providence RI USA Boston University School of Medicine Boston MA USA PubMed articlesGoogle scholar articles
  • Shiva Kumar R. Mukkamalla Division of Hematology and OncologyRoger Williams Medical Center 02908 Providence RI USA Boston University School of Medicine Boston MA USA PubMed articlesGoogle scholar articles
  • Vincent A. Armenio Division of Hematology and OncologyRoger Williams Medical Center 02908 Providence RI USA Boston University School of Medicine Boston MA USA PubMed articlesGoogle scholar articles
  1. a pouyan.changizzadeh{at}chartercare.org
  2. b 304-231-6779 shiva.mukkamalla{at}chartercare.org shiva.mukkamalla{at}gmail.com
  3. c varmenio{at}chartercare.org
View Full Text

Citation

Changizzadeh PN, Mukkamalla SKR, Armenio VA
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma

Publication history

  • Received July 11, 2017
  • Accepted November 13, 2017
  • First published December 19, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.